Advertisement.

SCNLF Projected Dividend Yield

Scancell Holdings PLC ( OTCBB : SCNLF )

Scancell Holdings is engaged in the discovery and development of novel vaccines for the treatment of cancer based on its immunotherapy platforms, ImmunoBody® and Moditope®. ImmunoBody® platform uses the body's immune system to identify, attack and destroy tumors. It consists of SCIB1 vaccine for treatment of metastatic melanoma; and SCIB2 vaccine for treatment of non-small cell lung cancer and other solid tumors. Moditope® is a platform that targets tumor associated stress-induced post-translational modifications. It includes Modi-1 vaccine for treatment of breast cancer, ovarian cancer, head and neck cancer, and other cancers; and Modi-2 vaccine for treatment of solid cancers.

20 YEAR PERFORMANCE RESULTS

SCNLF Dividend History Detail
SCNLF Dividend News
SCNLF Competitors News

# of Shares: 0

Closing Price: 0.18

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000